Endocan Level in Patients With Erectile Dysfunction and Relationship With Tadalafil Treatment
NCT ID: NCT05109377
Last Updated: 2021-11-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
90 participants
INTERVENTIONAL
2021-06-24
2021-12-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
5mg tadalafil
5mg tadalafil
Endocan
Endocan will measured before and after treatment
tadalafil
tadalafil
20mg tadalafil
20 mg tadalafil
Endocan
Endocan will measured before and after treatment
tadalafil
tadalafil
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Endocan
Endocan will measured before and after treatment
tadalafil
tadalafil
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Erectile dysfunction associated with hormonal disorders
* Drug related erectile dysfunction
18 Years
65 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ankara Training and Research Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Veysel Bayburtluoğlu
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Veysel Bayburtluoğlu
Role: PRINCIPAL_INVESTIGATOR
Ministry of Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Veysel Bayburtluoğlu
Ankara, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Veysel Bayburtluoğlu
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
E-93471371-514.10
Identifier Type: -
Identifier Source: org_study_id